Leading physiology and pharmacology researchers will speak in a four-part series centered on the gut microbiome--the microbe population living in the digestive tract--and its role in wound recovery, hypertension and nervous system function. The symposia series is organized by American Physiological Society (APS) President Jeff Sands, MD, and American Society for Pharmacology and Experimental Therapeutics (ASPET) President Edward T. Morgan, PhD, both of Emory University School of Medicine. The APS-ASPET Presidential Symposia Series will be part of the APS and APSET annual meetings at Experimental Biology 2019 in Orlando, Fla.
Workshop on Microbiome Research: What You Need to Know
Saturday, April 6, 1 p.m. -- Orange County Convention Center (OCCC) Room W311EF
Chair: Andrew D. Patterson, PhD, Pennsylvania State University; Co-chair: Meredith Hullar, PhD, University of Washington
Speakers:
"Experimental design for mouse studies"
Cathryn R. Nagler, PhD, University of Chicago
"Experimental design for human studies"
Meredith Hullar, PhD, University of Washington
"Bioinformatics: sequencing and metagenomics"
Mehrbod Estaki, MS, University of British Columbia
"Defining the chemical complexity of the microbiome through metabolomics"
Andrew D. Patterson, PhD, Pennsylvania State University
Microbiome. Gut Microbiome and Metabolic Disorders
Sunday, April 7, 8:30 a.m. -- OCCC Room W314
Chair: Jeff M. Sands, MD, Emory University School of Medicine; Co-chair: Edward T. Morgan, MD, Emory School of Medicine
Speakers:
"Acetate mediates a gut microbiome-brain-beta-cell axis: implications for obesity and cancer"
Rachel J. Perry, PhD, Yale University
"Antibiotic use and the gut microbiome"
Martin J. Blaser, MD, New York University
"The role of diet and small bowel microbiota in health and metabolic diseases"
Eugene B. Chang, MD, University of Chicago
Source: https://www.physiology.org/?SSO=Y
Parkinson's disease drug disrupts the gut microbiome by inducing iron deficiency